BUDA JUICE, INC. (BUDA) Stock Analysis

Price updated yesterday · SEC data refreshed 3 months ago · Not investment advice

BUDA JUICE, INC.

BUDA Consumer Defensive Beverages📄 SEC filings ↗
Valuation N/A
▾ What's in the 27/100 risk score? (higher = riskier)
Fundamental health (43%) 20/100 → +8.6
leverage 20/100 · Altman Z not scored — input unavailable (see Financial Health)
Smart money (short interest + insider buying) (31%) 31/100 → +9.7
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (26%) 33/100 → +8.5
Total27/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). It excludes the Altman Z score, whose retained-earnings input this filer does not report separately. See the Financial Health section for the full balance-sheet read.

💵 Price $8.18 · yesterday 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read BUDA

We are not publishing an intrinsic value for this one — the section below says exactly why. Everything on this page that comes straight from the filings and the tape is still here; treat the missing valuation as a known gap, not as a verdict on the business.

Where to start — the sections that matter most for this stock
  1. 1 Reported earnings & margins ↓
    What the company actually reported — unaffected by the valuation being held.
  2. 2 Balance sheet & book value ↓
    Assets, liabilities and equity as filed.
  3. 3 Who's selling & betting against it ↓
    Insider and short-interest behaviour needs no valuation model.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ A share-count quirk blocked the per-share math

The share count we read for BUDA looks wrong — common for multi-class / founder-controlled filers that report shares per share-class. That makes per-share figures (including intrinsic value) misleading, so we suppressed them. The company's total financials below are sound.

What to use instead: Lean on the totals — revenue, net income, cash flow — and the balance sheet. Multi-class share counts are being corrected; once fixed, the per-share valuation returns automatically.

This note is only about the single DCF fair-value number — BUDA's full financial statements, health scores, and written analysis are all below.

Loading insider & short-seller data…
Checking filings for failure warnings…

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
Not available for this filer

The Z-score needs working capital, retained earnings, EBIT, sales and total assets from the latest balance sheet, and at least one of those isn't reported in machine-readable form here — common for foreign private issuers. We leave it blank rather than compute a distress verdict from an estimated input. It doesn't affect the reported figures in the financial tables below.

Piotroski F-Score?Piotroski F-Score — A 9-point quality checklist scoring profitability, leverage, and operating efficiency.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
5 / 9
Mediocre
▾ The checks — what passed, what didn't (and what we couldn't measure)
  • Positive net income
    Net income $3.5M in FY2025.
  • Positive operating cash flow
    Operating cash flow $3.2M (was $4.0M the prior year).
  • Cash flow backs up reported profit
    Operating cash flow $3.2M vs net income $3.5M.
    Why this matters: When cash generated exceeds reported earnings, profits are high-quality (not propped up by accruals or one-time items).
  • Return on assets improving
    Return on assets 71.1% vs 95.8% a year ago.
    Why this matters: Is the company squeezing more profit out of each dollar of assets than last year? Rising = getting more efficient; falling = the opposite.
  • Debt load (vs assets)
    The filing reports no interest-bearing debt in either year (total assets $5.0M).
  • Short-term liquidity (current ratio)
    Current ratio 5.50x vs 4.69x a year ago.
  • Share count (dilution)
    Share count held roughly flat (0.0M → 0.0M year-over-year).
  • Pricing power (gross margin)
    Gross margin 44.6% vs 46.2% a year ago.
    Why this matters: Rising gross margin means stronger pricing power or lower input costs — a sign of competitive strength. Falling margin signals pressure.
  • Sales per asset (asset turnover)
    Asset turnover 2.54x vs 3.02x a year ago.
    Why this matters: Asset turnover measures how much revenue each dollar of assets generates. Rising = more productive use of the asset base.

Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.

Price$8.18
Model IVNot applicable — DCF couldn't price this stock. The other valuation lenses on this page (reverse-DCF, peers, sector lens — whichever apply to this filer) carry the read instead.

A standard discounted cash flow?DCF — Discounted Cash Flow — sums up all future cash a business will produce, adjusted for the fact that future dollars are worth less than dollars today.
Why it matters: It is the most fundamentally honest valuation method when applicable — but only works for companies with predictable, positive cash flow.
Reference: Best for: mature, profitable businesses. Fails for: pre-profit growth, banks, REITs.
Full explanation →
valuation is not meaningful for BUDA JUICE, INC. due to data limitations and an extreme valuation flag, indicating potential issues with per-share data. While the company is profitable and generates positive operating cash flow, the market is likely focused on its revenue growth and ability to expand its franchise. The number one quantifiable risk is the compressing gross margin, which could impact future profitability despite revenue growth.

⚠️ Operating CF declining

As of 3 months ago

Anatomy of a share

What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

Per-share economics aren't reliable for this filer. Its income statement or share count isn't fully reported to SEC EDGAR (common for foreign private issuers and thinly-disclosed OTC names), so we don't break it down per share here — the figures would be misleading. See the financial tables below for what is reported.

What you actually need to decide

Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

🐂 The Bull Case
The company must continue its revenue growth trajectory of 11.8%/yr and maintain positive operating cash flow to justify its market valuation and potential for future expansion.
🐻 The Bear Case
The compressing gross margin, which decreased from 46.2% to 44.6%, poses a significant risk, as continued compression could erode profitability despite revenue growth.
📌 Signposts to watch — update your view as these print
  • Next quarter's revenue growth rate
  • Gross margin trend in upcoming reports
  • Operating cash flow generation

The trend, in plain numbers (FY2024 → FY2025, latest reported)

Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

✅ Improving
  • Revenue grew +12% to $12.6M.
⚠ Worsening
  • Free cash flow fell to $2.9M.
  • Gross margin shrank to 45% (-2 pts).
  • Net income fell -1% to $3.5M.

Management & Leadership

BUDA JUICE, INC. is a privately held company, and specific executive information is not readily available in public filings for this analysis. The company operates in the beverage industry, focusing on healthy juice products.

What They Make

BUDA JUICE, INC. sells fresh juices and related healthy beverages to consumers seeking nutritious options. Their products are typically purchased by health-conscious individuals.

End Markets

Health & WellnessFood & BeverageConsumer Goods

Revenue Drivers

Juice sales
Smoothie sales
Franchise fees
Beta: 0.40

Why Is It Priced Like This?

Why Customers Pay

Nutritious and healthy options
Convenience for healthy eating
Variety of flavors
No discounted-cash-flow value for this filer We aren't publishing a discounted-cash-flow value here: the model's output failed our plausibility checks, so showing it would imply more precision than we have.

What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.

The market's pricing for BUDA JUICE, INC. is likely driven by expectations of continued revenue growth, which has been 11.8%/yr over the last year. Despite positive net income and operating cash flow, the extreme valuation flag and data issues suggest investors are looking beyond traditional cash flow metrics, potentially focusing on the company's expansion potential in the health beverage market.

Business Model & Valuation

How They Make Money

Juice sales
Smoothie sales
Franchise fees

Free Cash Flow DCF

Standard FCF DCF: positive free cash flow in a sector suited for cash-flow-based valuation.

Show advanced inputs
Revenue Growth11.8%
Eps Growth-1.2%
Historical Fcf Growth-11.7%
Sector Default5.0%
Best Estimate9.8%
Methodblend(70% revenue_cagr, 30% sector)
Growth Basistotal

What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project its revenue segments independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

Maturity & Competitive Position

Mature compounder

Moat Signals

Brand recognition in local markets
Customer loyalty for healthy products
Efficient supply chain for fresh ingredients

Revenue is growing at 11.8%/yr over 1yr, and net income has been positive for 2 out of 2 years.

Geography & Markets

BUDA JUICE, INC. is primarily a US-based company, though specific geographic revenue segmentation is not available from current data sources.

Geographic Risks

Concentration risk in domestic market
Competition from larger beverage companies

Market Signals

These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

Model neutral, tape neutral - aligned.
RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation →
(14)
45.4NeutralMomentum is balanced — neither overbought nor oversold.
MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →
BearishLine below signalThe fast trend is below the slow trend — short-term momentum is currently downward.
50-Day Average$9.68Price below (-15.5%)Price below its 50-day average = near-term downtrend.

Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

Data Quality & Risk Flags (4 notes — click to expand/collapse)

MEDIUM Operating CF declining
Guardrail Notes (3)
  • Illiquidity discount 15% applied (small/micro-cap — harder to exit, demand a margin).
  • Extreme valuation (P/IV withheld — see the note above); output dominated by data/units issue (often a multi-class share-count mismatch). Suppressed.
  • DATA UNAVAILABLE: per-share values suppressed due to missing/unreliable shares data.

Financial Statements (5-year tables — click to expand)

From BUDA JUICE, INC.'s SEC filings (EDGAR).

Income (5yr)

YearRevenueNet IncomeEPS
202512.6M3.5M$0.20
202411.3M3.6M$0.20

Cash Flow (5yr)

YearOperating CFCapEx− SBC & adj.Free Cash Flow
2025 3.2M 246,000 2.9M
2024 4.0M 684,000 3.3M

How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). This is the same owner-earnings FCF definition the valuation model uses.

Balance Sheet

Total Assets5.0M
Total Liabilities1.2M
Equity3.7M

Similar companies worth a look

Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.

PG
Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
🔔 Follow $BUDA — free insider alerts
One email when an insider buys $BUDA on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.